Drug Trial Radar · NCT07361302
A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well
Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,325
Planned (sponsor's estimate)
Start
Feb 17, 2026
Primary completion
Oct 2, 2027
Study completion Oct 2, 2027
Sponsor
- Lead sponsor
- Boehringer IngelheimBoehringer Ingelheim
- Sponsor type
- Industry
- First posted
- Jan 23, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is open to adults who had an acute stroke caused by a clot blocking a blood vessel in the brain (acute ischemic stroke). This study is for people who had an acute stroke or woke up with a stroke and were last seen well more than 4.5 hours before joining the study. Participants need to have imaging that shows there is brain tissue that can still be saved. They also should not be planned to receive a procedure to remove the blood clot. The purpose of this study is to find out whether a medicine called tenecteplase helps people recover from an acute stroke. Tenecteplase is already used to treat people within 4.5 hours after they had a stroke. This study tests if tenecteplase also helps if it is given more than 4.5 hours after the stroke. Participants are put into 2 groups randomly, which means by chance. One group gets tenecteplase as a single injection into a vein. The other group receives standard medical practice. Participants have an equal chance of receiving tenecteplase or the standard treatment. Participants are in the study for about 3 months. In the beginning, participants stay in the hospital for about 1 week. During the study, participants have 7 clinical examinations or visits. The last 2 of these visits will likely be done from home, allowing participants to complete certain assessments remotely. Doctors regularly test participants' recovery using a scale that measures the level of disability or dependence in daily activities. The results are compared between the 2 groups to see whether the treatment works. The doctors also check participants' health and take note of any unwanted effects.
Conditions
- Acute Ischemic Stroke
Interventions
TenecteplaseDrug
Tenecteplase
Standard of care treatmentDrug
Standard of care treatment
Primary outcomes
What the sponsor says the trial is designed to measure.
- modified Rankin Scale (mRS) score of 0-1 at Day 90Time frame: at day 90
Locations
258 sites in 16 countries. Site status is shown where the registry gives one.
Sanatorio Güemes
Buenos Aires, Argentina · Recruiting
Hospital Italiano de Buenos Aires
Ciudad Autonoma Buenos Aires, Argentina · Not yet recruiting
CEMIC
Ciudad Autonoma Buenos Aires, Argentina · Not yet recruiting
Hospital General de Agudos Dr. J. M. Ramos Mejia
Ciudad Autonoma Buenos Aires, Argentina · Not yet recruiting
Clinica La Sagrada Familia
Ciudad Autonoma Buenos Aires, Argentina · Recruiting
Fundacion para la Lucha contra las Enfermedades Neurologicas de la Infancia - FLENI
Ciudad Autonoma Buenos Aires, Argentina · Not yet recruiting
Complejo Medico de la Policia Federal Argentina Churruca Visca
Ciudad Autonoma Buenos Aires, Argentina · Not yet recruiting
Clinica Privada Velez Sarfield
Córdoba, Argentina · Recruiting
Nuevo Hospital San Roque
Córdoba, Argentina · Recruiting
Sanatorio Allende
Córdoba, Argentina · Recruiting
Sanatorio Privado Duarte Quiros De Clinica Colombo SA
Córdoba, Argentina · Recruiting
Sanatorio de la Canada
Córdoba, Argentina · Recruiting
Hospital Cordoba
Córdoba, Argentina · Recruiting
Hospital Privado de Comunidad
Mar del Plata, Argentina · Not yet recruiting
Hospital Universitario Austral
Pilar, Argentina · Recruiting
Hospital Privado de Rosario
Rosario, Argentina · Recruiting
Campbelltown Hospital
Campbelltown, New South Wales, Australia · Recruiting
Liverpool Hospital
Liverpool, New South Wales, Australia · Recruiting
John Hunter Hospital
New Lambton Heights, New South Wales, Australia · Recruiting
Royal Adelaide Hospital
Adelaide, South Australia, Australia · Recruiting
Eastern Health-Box Hill Hospital
Box Hill, Victoria, Australia · Recruiting
Monash Medical Centre
Clayton, Victoria, Australia · Recruiting
Royal Melbourne Hospital
Parkville, Victoria, Australia · Recruiting
MHAT "Puls" AD
Blagoevgrad, Bulgaria · Recruiting
MHAT Blagoevgrad, EOOD
Blagoevgrad, Bulgaria · Recruiting
MHAT Heart and brain
Burgas, Bulgaria · Recruiting
MHAT Sv. Ivan Rilski EOOD
Gorna Oryahovitsa, Bulgaria · Recruiting
MHAT City Clinic Saint Georgi Ltd
Montana, Bulgaria · Recruiting
MHAT Heart and brain
Pleven, Bulgaria · Not yet recruiting
University Multiprofile Hospital For Active Treatment Dr. Georgi Stranski EAD
Pleven, Bulgaria · Recruiting
UMHAT "Kaspela", EOOD
Plovdiv, Bulgaria · Recruiting
UMHAT "Sv. Georgi", EAD
Plovdiv, Bulgaria · Recruiting
UMHAT Kanev AD
Rousse, Bulgaria · Recruiting
UMHAT "Medika Ruse" OOD
Rousse, Bulgaria · Recruiting
Multiprofile Hospital For Active Treatment Hadji Dimitar OOD
Silven, Bulgaria · Recruiting
MHATNP "Sv. Naum" EAD
Sofia, Bulgaria · Recruiting
University First MHAT-Sofia "St. Joan Krastitel" EAD
Sofia, Bulgaria · Recruiting
Acibadem City Clinic Tokuda University Hospital EAD
Sofia, Bulgaria · Recruiting
Medical Military Academy MHAT Sofia
Sofia, Bulgaria · Recruiting
Multiprofile Hospital MHATEM 'Pirogov', Sofia
Sofia, Bulgaria · Recruiting
Showing 40 of 258 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.